MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Drug-induced Parkinsonism Mimicking Parkinson´s Disease in Patients Treated with Flunarizine for Migraine

N. Guragain, R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari (Kathmandu, Nepal)

Meeting: 2025 International Congress

Keywords: Drug-induced parkinsonism(DIP), Flunarizine, Parkinsonism

Category: Parkinsonism (Other)

Objective: To understand the pattern of movement disorders caused by migraine prophylactic medicine such as flunarizine.

Background: Migraine prophylactic treatments are usually taken for short or long term duration. Flunarazine is a calcium channel antagonist and also a mild dopamine antagonist. It is likely that its long term treatments might be associated with various movement disorders.

Method: During our outpatient clinic at Department of Neurology, Tribhuvan University Teaching Hospital in last 1 year, came across 2 interesting patients who were being treated for migraine with Flunarizine and later further treated as Parkinson´s Disease with levodopa and carbidopa in subsequent follow-up.

Results: Case 1: 72-year-old male, had been taking flunarizine 10mg for more than 2 years whose headache was well controlled after medicine presented to the local physician for his new symptoms of resting tremor in right hand. He was then prescribed with levodopa-carbidopa 125mg. However, his symptoms were static. During his visit to our clinic, patient was bradykinetic, prominent resting tremor in right side and whole-body tremulousness. After the stopping of flunarizine and levodopa-carbidopa and addition of trihexyphenidyl 1mg twice a day, patient significantly improved in 1 month. In subsequent follow-up after 2 months elicited complete resolution of features of parkinsonism.

Case 2: 68-year-old female, was prescribed with propranolol 20mg and flunarizine 10mg from our clinic for her frequent migraine episodes and was asked for follow-up in 3 months. However, patient presented in a year with improvement in headache episodes. On the other hand, she had increased generalized slowness, generalized body tremor and reduced facial expression as noticed by her family members. Flunarizine was changed to dosulepin 25mg and followed in 2 months with minimal bradykinesia and mask face and resolved tremor.

( Videos will be made available during poster presentation)

Conclusion: We should be cautious prescribing Flunarizine in elderly people, low-dose treatment, needed proper counselling beforehand regarding the likelyhood of motor adverse effects and regular monitoring of symptoms is needed. Early diagnosis cause reversal of symptoms and reduce the disease and economic burden of patients.

To cite this abstract in AMA style:

N. Guragain, R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari. Drug-induced Parkinsonism Mimicking Parkinson´s Disease in Patients Treated with Flunarizine for Migraine [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/drug-induced-parkinsonism-mimicking-parkinsons-disease-in-patients-treated-with-flunarizine-for-migraine/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/drug-induced-parkinsonism-mimicking-parkinsons-disease-in-patients-treated-with-flunarizine-for-migraine/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley